Date prepared: 06\/23\/2023<\/p>\n\n\n\n
Abbreviated name of the issuer: CELON PHARMA S.A.<\/p>\n\n\n\n
Subject: Appointment of existing members of the Company\u2019s Supervisory Board for another term <\/p>\n\n\n\n
Legal basis: Article 56 subs. 1 point 2 of the Act on Public Offering \u2013 current and periodical information<\/p>\n\n\n\n
Content of the report:<\/p>\n\n\n\n
The Management Board of Celon Pharma S.A. (\u201cCompany\u201d) hereby informs that the Ordinary General Meeting of the Company held on June 22, 2023 adopted resolutions on the appointment of the existing members of the Company\u2019s Supervisory Board:<\/p>\n\n\n\n
– Mr Bogus\u0142aw Galewski<\/p>\n\n\n\n
– Mr Krzysztof Kaczmarczyk<\/p>\n\n\n\n
– Mr Robert Rzemi\u0144ski<\/p>\n\n\n\n
– Ms Urszula Wieczorek<\/p>\n\n\n\n
– Mr Artur Wieczorek<\/p>\n\n\n\n
for a further term starting on January 1, 2024.<\/p>\n\n\n\n
Enclosed, the Company provides information on the above-listed Members of the Supervisory Board. <\/p>\n","protected":false},"excerpt":{"rendered":"